A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery. [electronic resource]
Producer: 20061113Description: 408-15 p. digitalISSN:- 1525-0016
- Animals
- Anticoagulants -- administration & dosage
- Antidotes -- administration & dosage
- Aptamers, Nucleotide -- administration & dosage
- Blood Coagulation -- drug effects
- Cardiopulmonary Bypass
- Factor IXa -- antagonists & inhibitors
- Heart -- drug effects
- Heparin -- pharmacology
- Models, Animal
- Nucleic Acid Conformation
- Protamines -- metabolism
- Swine
- Thrombin -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.